Frequently Asked Questions
The market is segmented based on Global Vascular Grafts and Peripheral Stents Market Segmentation, By Product Type (Vascular Graft and Peripheral Stent), Vascular Graft Raw Material Source (Synthetic, Biosynthetic, and Biological), Vascular Graft Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, and Hemodialysis Access), Peripheral Stent Artery Type (Carotid Artery, Fem-Pop Artery, Iliac Artery, and Infrapop Artery), Vascular Graft Application (Coronary Artery Disease, Vascular Occlusion, Aneurysm, Renal Failure, and Others), End Users (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Specialty Clinics, and Others) – Industry Trends and Forecast to 2031
.
The Global Vascular Grafts And Peripheral Stents Market size was valued at USD 3.72 USD Billion in 2023.
The Global Vascular Grafts And Peripheral Stents Market is projected to grow at a CAGR of 6% during the forecast period of 2024 to 2031.
The major players operating in the market include GSK, F. Hoffmann-La Roche, Novartis, Astrazeneca, Pfizer, Bristol,Myers Squibb, Sanofi, Amgen, Daiichi Sankyo, AB Sciences, Eisai, Genentech, Merck & Co..
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
